These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21719988)

  • 41. [New, pioneering PTH treatment of postmenopausal osteoporosis. Quick effect on bone density and bone formation].
    Törring O
    Lakartidningen; 2001 Oct; 98(42):4552-3. PubMed ID: 11715225
    [No Abstract]   [Full Text] [Related]  

  • 42. Short-term effects of parathyroid hormone on rat lumbar vertebrae.
    Sehmisch S; Erren M; Rack T; Tezval M; Seidlova-Wuttke D; Richter J; Wuttke W; Stuermer KM; Stuermer EK
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2014-21. PubMed ID: 19730209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein malnutrition attenuates bone anabolic response to PTH in female rats.
    Ammann P; Zacchetti G; Gasser JA; Lavet C; Rizzoli R
    Endocrinology; 2015 Feb; 156(2):419-28. PubMed ID: 25396268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Assessment of bone quality--present and future].
    Ito M
    Clin Calcium; 2004 Dec; 14(12):27-32. PubMed ID: 15577170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: a microarchitectural and mechanical study.
    Yang X; Chan YH; Muthukumaran P; Dasde S; Teoh SH; Lee T
    Bone; 2011 May; 48(5):1154-63. PubMed ID: 21334474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months increases cancellous bone formation and improves cancellous architecture: a study of iliac crest biopsies using histomorphometry and micro computed tomography.
    Fox J; Miller MA; Recker RR; Bare SP; Smith SY; Moreau I
    J Musculoskelet Neuronal Interact; 2005; 5(4):356-7. PubMed ID: 16340137
    [No Abstract]   [Full Text] [Related]  

  • 47. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
    Sato M; Zeng GQ; Turner CH
    Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
    Fox J; Miller MA; Recker RR; Turner CH; Smith SY
    Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats.
    Shen V; Birchman R; Xu R; Otter M; Wu D; Lindsay R; Dempster DW
    J Clin Invest; 1995 Nov; 96(5):2331-8. PubMed ID: 7593620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats.
    Vegger JB; Nielsen ES; Brüel A; Thomsen JS
    Bone; 2014 Sep; 66():287-95. PubMed ID: 24970039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parathyroid hormone and bone healing.
    Ellegaard M; Jørgensen NR; Schwarz P
    Calcif Tissue Int; 2010 Jul; 87(1):1-13. PubMed ID: 20428858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
    Li X; Ominsky MS; Warmington KS; Morony S; Gong J; Cao J; Gao Y; Shalhoub V; Tipton B; Haldankar R; Chen Q; Winters A; Boone T; Geng Z; Niu QT; Ke HZ; Kostenuik PJ; Simonet WS; Lacey DL; Paszty C
    J Bone Miner Res; 2009 Apr; 24(4):578-88. PubMed ID: 19049336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effectiveness of intermittent rat parathyroid hormone (1-34) treatment on low bone mass due to oestrogen or androgen depletion in skeletally mature rats.
    Montero M; Serfati D; Luna S; Díaz-Curiel M; Carrascal MT; Gomez S; De la Piedra C
    Aging Male; 2010 Mar; 13(1):59-73. PubMed ID: 20148746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
    Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
    Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of osteoporosis: role of bone-forming agents.
    Reginster JY; Halkin V; Henrotin Y; Gosset C
    Osteoporos Int; 1999; 9 Suppl 2():S91-6. PubMed ID: 10525731
    [No Abstract]   [Full Text] [Related]  

  • 56. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of micro-CT assessment of 3-D bone microstructure in preclinical and clinical studies.
    Jiang Y; Zhao J; Liao EY; Dai RC; Wu XP; Genant HK
    J Bone Miner Metab; 2005; 23 Suppl():122-31. PubMed ID: 15984427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone.
    Pettway GJ; Schneider A; Koh AJ; Widjaja E; Morris MD; Meganck JA; Goldstein SA; McCauley LK
    Bone; 2005 Jun; 36(6):959-70. PubMed ID: 15878317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization.
    Misof BM; Roschger P; Dempster DW; Zhou H; Bilezikian JP; Klaushofer K; Rubin MR
    J Bone Miner Res; 2016 Jan; 31(1):180-9. PubMed ID: 26111772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Assessment of bone quality. Bone quality and osteoporosis treatment].
    Mashiba T
    Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.